#VOR

@culturesurfer.bsky.social

3 weeks ago

Das kommt, weil Moskau unmögliche Forderungen an Ukraine, Europa und USA stellt.

Das haben die schon #vor dem Krieg getan: Unmögliche Forderungen, die man nicht erfüllen kann. Dann sind sie wieder einmal einmarschiert in Ukraine in 2022.

1 0 0 0

DinoSetoVigo

@dinosetovigo.bsky.social

1 month ago

Mi cara cuando le robaron el gol al Panda en Cornellá...
#EspanyolCelta #Celta #VAR #VOR #Borja #Iglesias

1 0 0 0

DinoSetoVigo

@dinosetovigo.bsky.social

1 month ago

A partir de ahora a todos los que se quejen por las decisiones del VAR, Tebas tendrá derecho a ir en persona y evitar que puedan ver el partido...
#Celta #EspanyolCelta #LaLiga #Tebas #VAR #VOR

1 0 0 0

Star Ryderr

@star-ryder.bsky.social

1 month ago

Star in a light tea spandex crop top that’s unzipped to reveal their tantalizing cleavage. In their fingers they hold a tiny pill capsule with a little plastic man inside up to the camera

Reminder to take ur meds ✨🥰

#maneater #vore #femdom #kink #goddess #giantess #vor #bdsm #nsfw #queer #yumyum

10 4 0 0

Epian Gidamaf (Ambreiaju)

@gidamaf.bsky.social

1 month ago

postarile din aceasta diminoapte™ creaza un rulaj puternic! in alte cuvinte, sunt pe val !!!!!

haterii urasc! #haterii #nu #vor #reusi
#910pasidebine

0 0 1 0

Katzenminze

@thomas-katzenminze.bsky.social

1 month ago

Gerne!
Kernfusion hätte trotz der Fortschritte #vor 20 Jahren eine Lösung sein können, nicht erst #in 20 Jahren.
Start-Ups, für die der Misserfolg anders als bei öffentlicher Forschungen eine Option ist, kommen vielleicht etwas schneller zum Ziel. Die Raketen von Musk explodieren aber auch ständig.

0 0 0 0

Der Kinobaum

@kinobaum.bsky.social

1 month ago

Minnesota: Friedrich Merz kritisiert Gewaltanwendung in den USA als besorgniserregend Nach dem Tod eines Demonstranten in Minneapolis äußert Bundeskanzler Friedrich Merz Kritik. Er gehe davon aus, dass die US-Behörden nun aufklären, ob es wirklich eine Bedrohung der Beamten gegeben hab...

Friedrich #Merz findet das Ausmaß an Gewaltanwendung in den #USA "besorgniserregend". Wer da Gewalt gegen wen anwendet, lässt unser Bundeskanzler offen.
#Minnesota #Minneapolis #feige #kriechen #vor #Trump

0 0 0 0

Einfach Kurt

@einfachkurt.bsky.social

1 month ago

Kartenausschnitt Hauptbahnhof Wien

Liebe Leute beim #VOR
Was in der VOR-App als Strecke für den Umstieg von den Bahnsteigen zur U-Bahn angezeigt wird, ist ein schlechter Witz. Schaut sich das niemand an?

1 0 0 0

Star Ryderr

@star-ryder.bsky.social

2 months ago

Star holds a tiny naked plastic man up to their luscious lips

Time for a a tasty lil treat ✨

#giantess #vor #tiny #sph

9 2 0 0

Palki, Cat Derg, The Snack! 🔞

@palkicatderg.bsky.social

2 months ago

Cw: vore, digestion
Cat Derg, down the birdie gut, then into the birdies food processor, to become more birb fat, oop, tail scarf isnt needed, booouuurrrp <3 #vor

43 4 0 0

Berufshobbywinzer Schroeder

@schroedern.bsky.social

2 months ago

#vor #Ort ?

1 0 0 0

Atomos1 📎🌈🏳️‍🌈🏳️‍⚧️

@ncoastbruin.bsky.social

3 months ago

Just because I wish (often) that I was back in #Wales.

#ValeOfRheidolRailway
#VOR
#Aberystwyth

1 0 0 1

ZePG – Zentrum Patientenschulung und Gesundheitsförderung e. V.

@zepg.de.web.brid.gy

3 months ago

DRV-Fortbildungen 2026-12-10 10.12.2026 – 15:00 bis 16:30, online Wie gelingt die verhaltensmedizinisch orientierte Rehabilitation? Themen des Termins Referent:innen und Moderation DRV-Materialien Stand: Dezember 2025 Anmeldung zu der Fortbildungsreihe „90-Minuten online“ Mit diesem Formular können Sie sich für die Fortbildungsreihe anmelden. Die Anmeldung bezieht sich auf alle noch ausstehenden Termine. Sie können selbstverständlich auch nur an den Terminen

0 0 0 0

Small Cap Strategist

@smcapstrategist.bsky.social

3 months ago

Most Searched, Tuesday December 9, 2025 – Crystal Equity Research

Most searched small-cap stocks, Tue Dec 9th - #RXRX #EXK #NVTS #RR #TROX #XCUR #IRBT #VOR #SNTI #SBET #UUUU #SEI #SANA #PLUG #ONDS #GCT #CLSK #BITF #BBAI - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0

Stock Master

@stockmaster70.bsky.social

3 months ago

📢 Stocks Trending NOW: #NVDA #XCUR #VOR #WVE #PSKY #ATMC #CVS #SNTI #AZO #CPB

0 0 0 0

PRISM MarketView

@prismmarketview.bsky.social

3 months ago

PRISM M☀️rning M☀️vers
Premarket Gainers
AlphaTime Acquisition Corp ( #ATMC) up 602%
Exicure, Inc. ( #XCUR) up 70%
Vor Biopharma Inc. ( #VOR) up 53%
AlphaVest Acquisition Corp ( #ATMV) up 20%
Premarket Decliners
Top Wealth Group Holding Limited ( #TWG) down 48%
Cemtrex, Inc. ( #CETX) down 16%

0 0 0 0

((***Tiefenkultur**)) @kassiopeia_v7

@tiefenkultur.bsky.social

3 months ago

Können wir den #Liberalismus #liebenlernen?

#Politik der #Bescheidenheit

Wer behauptet nicht von sich, #liberal zu sein? Trotzdem vegetiert die Partei, die den #Liberalismus für sich reklamiert, #vor den Toren der #Parlamente dahin.

1 0 1 0

Small Cap Strategist

@smcapstrategist.bsky.social

3 months ago

Trade Alerts, Monday November 24, 2025 – Crystal Equity Research

Small-cap stocks gapping up in trading, Mon Nov 24th - #YDES #HSAI #VOR #SLRX #NXTC #MXL #ENLV #CLLS #BLFY #AEHL #MAGN #GNK #CMDB #BFLY - More: crystalequityresearch.com/trade-alerts... - #smallcap

0 0 0 0

Slappy

@olslappo.bsky.social

3 months ago

5k Part 4
As advertised, Gwen eating ah just a buncha people. how many? One hopes five thousand but really I don't think that many people can fit onto that one plate and you also gotta account for bots too so maybe like, 2300-5000 plus or minus a few hundred
#furry #nsfw #vor #micro #macro

25 7 1 0

StockTitan

@stocktitan.net

4 months ago

Vor Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update Vor Bio (NASDAQ: VOR) reported Q3 2025 results and a broad clinical and corporate update on November 13, 2025. Multiple Phase 3 readouts for telitacicept showed positive efficacy and favorable safety across indications: gMG (96.2% ≥3‑point MG‑ADL response at 48 weeks), Sjögren’s disease (placebo‑adjusted ESSDAI −3.8; 71.8% vs 19.3% ≥3‑point ESSDAI at 24 weeks), SLE (67.1% vs 32.7% modified SRI‑4 at Week 52), and IgA nephropathy (55% reduction in 24h‑UPCR at 39 weeks). Corporate: raised expected gross proceeds of $115 million in Nov 2025 offering; cash and marketable securities were $170.5M as of Sept 30, 2025, projected to fund operations into Q2 2027.Q3 financials show a net loss of $812.7M driven by a loss on warrant liabilities and total liabilities of $2.402B.

#VOR Vor Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update

www.stocktitan.net/news/VOR/vor-bio-reports...

0 0 0 0

((***Tiefenkultur**)) @kassiopeia_v7

@tiefenkultur.bsky.social

4 months ago

In jedem #Moment und mit jedem neuen #Atemzug sollte man erneuert und wieder erneuert sein.

Es gibt nur einen #Weg, in ein #neuesLeben geboren zu werden: #Vor dem #Tod zu #sterben

2/2

0 0 0 0

StockTitan

@stocktitan.net

4 months ago

Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock Vor Bio (Nasdaq: VOR) priced an underwritten public offering of 10,000,000 common shares at $10.00 per share, generating expected gross proceeds of $100 million before underwriting discounts, commissions and offering expenses. The offering is expected to close on or about November 12, 2025. Vor Bio granted underwriters a 30-day option to purchase up to an additional 1,500,000 shares at the public offering price, less underwriting discounts and commissions. All shares are being sold by Vor Bio pursuant to a shelf registration declared effective by the SEC on March 31, 2025. Final prospectus supplement will be filed with the SEC and copies will be available from the listed underwriters.

#VOR Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock

www.stocktitan.net/news/VOR/vor-bio-announc...

0 0 0 0

StockTitan

@stocktitan.net

4 months ago

Vor Bio Announces Proposed Public Offering of $100 Million of Common Stock Vor Bio (Nasdaq: VOR) commenced an underwritten public offering of $100 million of common stock on November 10, 2025, and intends to grant underwriters a 30-day option to purchase up to an additional $15 million of shares at the public offering price, less underwriting discounts and commissions.All shares are being offered by Vor Bio and the offering is subject to market and other conditions with no assurance it will be completed as proposed. J.P. Morgan, Jefferies, Citigroup and TD Cowen are joint book-running managers. The offering uses a shelf registration declared effective March 31, 2025, and will be made by prospectus supplement filed with the SEC.

#VOR Vor Bio Announces Proposed Public Offering of $100 Million of Common Stock

www.stocktitan.net/news/VOR/vor-bio-announc...

0 0 0 0

Ulrich Kiermayr

@ulrich.kiermayr.at

4 months ago

Wer findet den Fehler?

#öbb #wienerlinien #vor #s80 #4020 #netzplan

7 1 3 0

StockTitan

@stocktitan.net

4 months ago

Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China Treatment with telitacicept for 39 weeks resulted in a rapid, clinically meaningful, and statistically significant reduction in proteinuria, with a favorable safety profile Telitacicept demonstrated a 55% reduction in 24-hour urine protein-to-creatinine ratio (24h-UPCR) at 39 weeks compared with

#VOR Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China

www.stocktitan.net/news/VOR/telitacicept-ac...

0 0 0 0

StockTitan

@stocktitan.net

4 months ago

Telitacicept Demonstrates Sustained Efficacy and Favorable Safety Profile in 48-Week China Phase 3 Open-Label Extension Generalized Myasthenia Gravis Data Vor Bio (Nasdaq: VOR) collaborator RemeGen presented 48-week open-label extension data for telitacicept in generalized myasthenia gravis on Oct 29, 2025.Key efficacy: continuous-treatment patients had a mean -7.5 MG-ADL change and crossover patients -6.3 at week 48; continuous patients had mean -9.8 QMG change and crossover -9.3. 96.2% of continuous and 90.2% of crossover patients reached ≥3-point MG-ADL improvement; most adverse events were mild‑to‑moderate with no new safety signals.

#VOR Telitacicept Demonstrates Sustained Efficacy and Favorable Safety Profile in 48-Week China Phase 3 Open-Label Extension Generalized Myasthenia Gravis Data

www.stocktitan.net/news/VOR/telitacicept-de...

0 0 0 0

StockTitan

@stocktitan.net

4 months ago

Vor Bio Announces Late-Breaking Oral Presentation of China Phase 3 IgA Nephropathy Clinical Study at American Society of Nephrology’s Kidney Week 2025 Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that clinical data from Stage A of a Phase 3 study in China sponsored by Vor Bio’s collaborator RemeGen Co., Ltd

#VOR Vor Bio Announces Late-Breaking Oral Presentation of China Phase 3 IgA Nephropathy Clinical Study at American Society of Nephrology’s Kidney Week 2025

www.stocktitan.net/news/VOR/vor-bio-announc...

0 0 0 0

StockTitan

@stocktitan.net

4 months ago

Vor Bio Announces Publication of China Phase 3 Study of Telitacicept in Systemic Lupus Erythematosus in The New England Journal of Medicine Trial met primary endpoint achieving statistically significant improvement in disease activity, with 67.1% of patients responding with telitacicept versus 32.7% with placebo Dual inhibition of BAFF and APRIL validated as a transformative B-cell approach, highlighting telitecicept’s potential as a

#VOR Vor Bio Announces Publication of China Phase 3 Study of Telitacicept in Systemic Lupus Erythematosus in The New England Journal of Medicine

www.stocktitan.net/news/VOR/vor-bio-announc...

0 0 0 0